Ashish Goyal

Also affiliated with Manipal University Jaipur

MedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Suppression of hepatitis B virus through therapeutic activation of RIG-I and IRF3 signaling in hepatocytes”.

Suppression of hepatitis B virus through therapeutic activation of RIG-I and IRF3 signaling in hepatocytes

iScience(2021)10.1016/j.isci.2020.101969

N/A

0.524DataRank · unranked

32 citations

Ashish Goyal, Alan S. Perelson, Yuji Ishida, Takeshi Saito, Michael Gale +1 more

HIV influences clustering and intracellular replication of hepatitis C virus

Journal of Viral Hepatitis(2020)10.1111/jvh.13429

N/A

0DataRank · unranked

9 citations

Alan S. Perelson, Abraham J. Kandathil, Jeffrey Quinn, Ashwin Balagopal, Ruy M. Ribeiro +1 more

Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission

Viruses(2021)10.3390/v13101921

N/A

0DataRank · unranked

19 citations

Ashish Goyal, Chloe Bracis, Mia Moore, Elizabeth M. Krantz, Elizabeth R. Brown +10 more

Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication

AIDS(2021)10.1097/qad.0000000000003116

N/A

0DataRank · unranked

2 citations

Ashish Goyal, Ruy M. Ribeiro, Guido Massaccesi, Justin R. Bailey, David L. Thomas +2 more

Modeling explains prolonged SARS-CoV-2 nasal shedding relative to lung shedding in remdesivir-treated rhesus macaques

iScience(2022)10.1016/j.isci.2022.104448

N/A

0DataRank · unranked

22 citations

Elizabeth R. Duke, E. Fabián Cardozo-Ojeda, Joshua T. Schiffer, Ashish Goyal

Estimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission

Science Advances(2022)10.1126/sciadv.abj5666

N/A

0DataRank · unranked

9 citations

Matthew R. Gardner, Bryan T. Mayer, Keith R. Jerome, Michael Farzan, Joshua T. Schiffer +2 more

Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac157

N/A

0DataRank · unranked

5 citations

Alex Churkin, Danny Barash, Scott J. Cotler, Amir Shlomai, Ohad Etzion +2 more

Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.01015-23

N/A

0DataRank · unranked

6 citations

Shadisadat Esmaeili, E. Fabián Cardozo-Ojeda, Ashish Goyal, Judith M. White, Stephen J. Polyak +2 more

Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response

Science Advances(2020)10.1126/sciadv.abc7112

N/A

0DataRank · unranked

200 citations

E. Fabián Cardozo-Ojeda, Joshua T. Schiffer, Ashish Goyal

Modeling hepatitis D virus kinetics during bulevirtide monotherapy: challenges and solutions

PubMed(2025)10.48550/arxiv.2505.12286

N/A

0DataRank · unranked

0 citations

Louis Shekhtman, Ashish Goyal, Elisabetta Degasperi, Maria Paola Anolli, Sara Uceda Renteria +9 more